GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,616.00p
   
  • Change Today:
    -12.50p
  • 52 Week High: 1,671.50
  • 52 Week Low: 1,264.00
  • Currency: UK Pounds
  • Shares Issued: 4,066.69m
  • Volume: 10,328,878
  • Market Cap: £65,718m
  • RiskGrade: 129
  • Beta: 0.01

GSK Overview

We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book n/a  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

GSK Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 34,099.00 6,968.00 115.90p 14.5 n/a -6% 80.00p 4.8%
31-Dec-21 24,696.00 3,599.00 90.56p 22.2 n/a -22% 80.00p 4.0%
31-Dec-22 29,324.00 5,628.00 139.70p 10.3 0.2 +54% 44.00p 3.1%
31-Dec-23 30,328.00 6,064.00 155.10p 9.4 0.9 +11% 58.00p 4.0%
31-Dec-24 31,376.00 3,477.00 159.30p 8.5 2.8 +3% 61.00p 4.5%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GSK Company Announcements

Transaction in Own Shares 06-Oct-2025 07:00 RNS
Transaction in Own Shares 03-Oct-2025 07:00 RNS
Transaction in Own Shares 02-Oct-2025 07:00 RNS

GSK ShareCast News

London midday: UK stocks keep grinding towards y... 03-Oct-2025 ShareCast
Emma Walmsley to step down as chief executive of... 29-Sep-2025 ShareCast
Trump to impose tariffs of 100% on branded drug ... 26-Sep-2025 ShareCast

GSK Top Newspaper Links

GSK boss Emma Walmsley to receive benefits for y... 06-Oct-2025 Times
GSK’s Emma Walmsley to be replaced as chief exec... 29-Sep-2025 Guardian
GlaxoSmithKline scraps sale of old drugs 05-Dec-2014 Telegraph

Latest GSK Director Deals

Traded Action Notifier PriceAmountValue
19-Sep-25 Buy Vishal Sikka 1,512.21p 1,654 £25,011.99
19-Sep-25 Buy Jeannie Lee 1,512.21p 478 £7,228.38
19-Sep-25 Buy Harry (Hal) C. Dietz 1,512.21p 480 £7,258.62

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

GSK Market Data

Currency UK Pounds
Share Price 1,616.00p
Change Today -12.50p
% Change -0.77 %
52 Week High 1,671.50
52 Week Low 1,264.00
Volume 10,328,878
Shares Issued 4,066.69m
Market Cap £65,718m
Beta 0.01
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average
36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average
Income Not Available
Growth Not Available

GSK Dividends

  Latest Previous
  Q2 Q1
Ex-Div 14-Aug-25 15-May-25
Paid 09-Oct-25 10-Jul-25
Amount 16.00p 16.00p

Trades for 06-Oct-2025

Time Volume / Share Price
15:02 0 @ 1,623.50p
15:02 0 @ 1,623.50p
15:02 0 @ 1,623.50p
15:02 0 @ 1,623.50p
15:02 0 @ 1,623.50p

GSK Key Personnel

CEO Emma Walmsley

Top of Page